FINWIRES · TerminalLIVE
FINWIRES

特朗普称伊朗在水路压力之外实力不足,与此同时,万斯前往伊斯兰堡举行关键会谈。

-- 美国总统唐纳德·特朗普周五表示,伊朗除了利用国际水道进行短期施压外,别无其他筹码,并强调谈判是其唯一可行的出路。 特朗普在Truth Social网站上发帖称:“伊朗人似乎没有意识到,除了利用国际水道对世界进行短期勒索之外,他们别无其他手段。他们今天还能活着,唯一的理由就是谈判!” 周五,特朗普在接受《纽约邮报》采访时表示,预计将在24小时内就伊朗谈判做出决定,这标志着达成潜在协议的关键窗口期。 据报道,当被问及谈判成功的可能性时,特朗普表示:“我们将在大约24小时内知道结果。” 他还补充说,美国正在为舰艇配备“最好的弹药”和比以往部署的更先进的武器,并表示美军目前处于比以往行动更有利的地位。 特朗普表示,如果未能达成协议,美国将动用这些能力,并警告称任何行动都将“非常有效”。已联系白宫寻求置评。 在美伊伊斯兰堡会谈前夕,油价维持在周四水平附近。西德克萨斯中质原油上涨0.34%至每桶98.20美元,布伦特原油上涨0.80%至每桶96.69美元,而穆尔班原油下跌1.66%至每桶97.97美元。

Related Articles

Asia

Easou Technology Invests $7.7 Million in Wealth Product Using Idle Top-up Placing Funds

Easou Technology (HKG:2550) said it has subscribed to a $7.7 million wealth management product issued by Huatai International Financial Products, using idle proceeds from its earlier placings, according to a Friday Hong Kong bourse filing.Shares of the digital service firm were down over 1% in Monday's late-morning trade.The investment, guaranteed by Huatai International Financial, carries an annualized return of 1.07% to 5.83% over a term ending March 30, 2027.Easou said the move aims to enhance the utilization efficiency and returns on idle funds while maintaining liquidity.

$HKG:2550
Asia

SSY Group Gets Chinese Regulatory Nod for Production, Registration of Two Products

SSY Group (HKG:2005) said it received Chinese regulatory approval to begin drug production and registration of its diltiazem hydrochloride in injection form, according to a Hong Kong bourse filing Monday.The drug is mainly used to treat a heart condition known as supraventricular tachycardia and the emergency treatment of abnormally high blood pressure during surgery.The firm's propranolol hydrochloride injection was also approved for production and registration by China's National Medical Products Administration.The product is mainly used to treat supraventricular tachyarrhythmias and ventricular arrhythmias.

$HKG:2005
Asia

Amplitude Energy Says Australian Retirement Trust Raises Stake

Amplitude Energy (ASX:AEL) said Australian Retirement Trust raised its stake in the firm to 6.3% as of Friday from 5.1% as of April 2, according to a Monday Australian bourse filing.Australian Retirement Trust now holds nearly 19 million votes in the firm.

$ASX:AEL